Case | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | Median (IQR) |
---|---|---|---|---|---|---|---|---|---|---|
Age - years | 70 | 66 | 53 | 83 | 80 | 62 | 51 | 78 | 67 | 67 (63–78) |
Gender | Male | Female | Female | Male | Female | Male | Male | Female | Male | Â |
Hospital stay - days | 20 | 10 | 22 | 29 | 5 | 15 | 5 | 12 | 22 | 15 (10–22) |
Comorbidities | Cerebral infarction, hypertension | Hypertension | Hypertension | Cerebral infarction, hypertension | Hypertension, coronary heart disease, renal dysfunction, lacunar infarction, slow to emphysema | NA | Hypertension (level 3 with very high risk), gout | Hypertension, coronary artery disease | NA | Â |
Hyaline thrombus distribution of major organsa | ||||||||||
 Lung | √ | √ | √ | √ | √ | √ | √ | √ | √ |  |
 Kidney |  | √ |  |  |  |  |  |  | √ |  |
 Heart |  |  |  | √ |  |  |  |  |  |  |
 Brain | √ | √ | √ |  | √ |  |  |  |  |  |
 Spleen | √ | √ | √ |  | √ |  |  |  |  |  |
Laboratory findings of coagulation relevant indicesb | ||||||||||
 PLT - × 109/L | 63 | 127 | 116 | 134 | 76 | 167 | 161 | 66 | 174 | 161.0 (134.0–167.0) |
 PT - s | 19.2 | 13.5 | 13 | 12 | 14.5 | 13.7 | 126.2 | 19.3 | 12 | 12.5 (12.0–13.1) |
 APTT - s | 45.2 | 27.9 | 23.4 | 35.1 | 46.3 | 41.9 | 83.5 | 41.6 | 35.1 | 31.5 (26.8–35.1) |
 TT - s | 65.2 | 14.9 | 16.7 | 16.2 | 18.2 | 16.7 | 27.8 | NA | 16.2 | 16.5 (16.2–16.7) |
FIB - g/L | 12.73 | 45.43 | 18.76 | 3.36 | 1.3 | 1.3 | 15.94 | 77.33 | 3.36 | 1.3 (1.3–2.3) |
 D-dimer - μg/mL | 1.5 | 6.2 | 2.2 | 3.6 | 6.1 | 3.6 | 3.6 | NA | NA | 3.6 (3.3–3.6) |
 DIC | 6 | 5 | 5 | 5 | 5 | 4 | 5 | 6 | 5 | 5.0 (5.0–5.0) |